Novartis Pharma Schweiz Revenue and Competitors

Switzerland

Location

#3288

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • Novartis Pharma Schweiz's estimated annual revenue is currently $10.3M per year.(i)
  • Novartis Pharma Schweiz's estimated revenue per employee is $201,000

Employee Data

  • Novartis Pharma Schweiz has 51 Employees.(i)
  • Novartis Pharma Schweiz grew their employee count by 89% last year.

Novartis Pharma Schweiz's People

NameTitleEmail/Phone
1
Senior Fellow/Team Coordinator/Application Owner eLN@TRD/Network Leader Lab AutomationReveal Email/Phone
2
Digital Product Owner (Tech)Reveal Email/Phone
3
Executive Director, CEO & Executive CommunicationsReveal Email/Phone
4
Process mining ownerReveal Email/Phone
5
Product Owner, data42Reveal Email/Phone
6
Global Expense Process OwnerReveal Email/Phone
7
System Governance Manager & System Owner TRD SAPReveal Email/Phone
8
LDC Product Cost Controlling Manager & Global Process Owner Product Cost SimulationReveal Email/Phone
9
Omnichannel Product OwnerReveal Email/Phone
10
Global ESG Reporting Process OwnerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.5M522%N/AN/A
#2
$155.6M7747%N/AN/A
#3
$40.8M20310%N/AN/A
#4
$245.6M1222-24%N/AN/A
#5
$142.3M7080%N/AN/A
#6
$141.1M702-9%N/AN/A
#7
$16.7M8328%N/AN/A
#8
$16.5M828%N/AN/A
#9
$21.3M10615%N/AN/A
#10
$13.7M68-1%N/AN/A
Add Company

What Is Novartis Pharma Schweiz?

At Novartis, our mission is to discover new ways to improve and extend people's lives. We use science-based innovation to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.

keywords:N/A

N/A

Total Funding

51

Number of Employees

$10.3M

Revenue (est)

89%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M51-11%N/A
#2
$5.5M5134%N/A
#3
$14M51-4%N/A
#4
$4.7M512%N/A
#5
$75M514%N/A